en
FAQ
Novartis was founded in December 1996 by the merger of two successful international Swiss-owned companies with complementary product lines – Ciba-Geigy Ltd. and Sandoz Ltd.
Novartis is one of the world's leading healthcare companies. We are committed to improving the well being of people by creating products in the areas of pharmaceuticals, consumer health, eye-care, generics and animal health.
Each company brought more than 100 years of experience in providing innovative healthcare solutions to the world from their separate headquarters in Basel, Switzerland.
Novartis comes from the Latin term “novae artes”, which means "new arts" or "new skills". In essence, Novartis means utilizing scientific research, imagination, and new technologies to provide ever-greater benefits for humankind.
Our annual sales are approximately USD 41.5 billion and our investment in research and development last year was over USD 7.2 billion.
Yes. Headquartered in Basel, Switzerland, the Novartis Group operates in more than 140 countries around the world.
The Novartis Group employs approximately 100,000 people worldwide.
Our roots in Canada go back to the 1920s when both Ciba and Sandoz were established in Montreal, and to the 1940s, when J.R. Geigy opened in Toronto.
The Canadian merger took effect on January 1, 1997.
Novartis Pharmaceuticals Canada Inc. employs approximately 650.
Novartis Pharmaceuticals Canada Inc. has its head office in Dorval, Quebec.
You can get contact information for all of Novartis Pharmaceuticals Canada Inc.'s affiliates by clicking the following link.
Each year, Novartis Pharmaceuticals Canada Inc. conducts clinical trials at hundreds of sites across the country, involving thousands of patients, researchers, and investigators. Notable among these studies are those seeking new treatments for:
- Cardiovascular diseases
- Diabetes
- Irritable bowel syndrome
- Schizophrenia
- Organ transplantation
- Allergies "bone diseases"
- Glaucoma
- Retinal diseases
- Different types of cancer
ABOUT NOVARTIS
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis
